focus -WSS

focus

author：focus 2025-10-01 17:20:06 - browse：92

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Today's health inequities arise from racist U.S. history, say experts

entertainment

WSS

The perfect storm of weather conditions that led to the devastating wildfires in Maui

First transplant of an entire human eye performed

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

White House drug shortages task force keeps mum with Congress

Ohio still needs to do more to protect the right to abortion

entertainment

focus

focus

Hepatitis C has a cure — but many Americans still lack access to it

Newly revealed memo details efforts to keep Trump in power following election loss

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Newly revealed memo details efforts to keep Trump in power following election loss

23andMe had bad news about my health. I wish a person had delivered it

How state and local governments are sidelining science

In age of alternative facts, a scholarly course on calling out crap

How state and local governments are sidelining science

23andMe had bad news about my health. I wish a person had delivered it

Publishing genetic code of viruses could cause disaster

hotspot

Covid's long

Cancer diagnosis changes perspective doctor, former hospital CEO

After decades in use, heart stents finally beat placebo

White House drug shortages task force keeps mum with Congress

Healthy food access boosts outcomes in two studies

What health policies could hitch a ride on a spending bill?

entertainment

focus

focus

leisure time